Provided by Tiger Trade Technology Pte. Ltd.

Hillhouse Capital Related

455.580
-14.279-3.04%
Number of Gainers:2
Number of Losers:46
Number of Flat:3
PE:- -
High:467.950
Open:467.950
Low:449.431
Close:469.859
Volume:208.14M
Turnover:6.45B
Market Cap:2.92T
Float Cap:2.00T

Loading ...

Jinxin Fertility Proposes to Launch ABS Program

Reuters
·
Sep 29

Jinxin Fertility Plans Asset-Backed Special Scheme, Expects to Issue Asset-Backed Securities

Stock News
·
Sep 29

Jinxin Fertility Group - Co and Project Manager Apply to SSE for Abs Program

THOMSON REUTERS
·
Sep 29

Jinxin Fertility Group - Aggregate Issuance Size of Abs to be Issued is Expected to be Rmb1,930 Mln

THOMSON REUTERS
·
Sep 29

Jinxin Fertility Group - Sanya Jinshu Will Conditionally Agree to Transfer Entire Equity Interests in Hengyu to Abs Program

THOMSON REUTERS
·
Sep 29

BlackRock Increases Stake in WuXi AppTec (02359) by About 1.167 Million Shares at Roughly HK$179.83 Each

Stock News
·
Sep 29

FMR LLC Raises Stake in GENSCRIPT BIO (01548) by 6.846 Million Shares at About HK$40.25 Each

Stock News
·
Sep 29

EDDING GENOR (06998) Spends HK$1.6999 Million to Repurchase 1 Million Shares on September 29

Stock News
·
Sep 29

Shenzhen Lifotronic Technology Secures Medical Device Registration Certificate for Photon Therapeutic Apparatus

Stock News
·
Sep 29

ZYLOXTB Spends HK$1.1383 Million to Repurchase 53,000 Shares on September 29

Stock News
·
Sep 29

Meituan Stock Sheds 2.0% in Hong Kong

Dow Jones
·
Sep 29

AH Premium Statistics for September 29

Stock News
·
Sep 29

Innovent Says Trispecific Antibody Ibi3003 Posts 84.6% ORR at Phase 1 RP2D in Relapsed/refractory Multiple Myeloma

Reuters
·
Sep 29

2026 Ims Oral Presentation: Innovent Announces Updated Phase 1 Clinical Data of Trispecific Antibody Ibi3003 (Gprc5d/Bcma/Cd3) in Patients with Relapsed or Refractory Multiple Myeloma

THOMSON REUTERS
·
Sep 29

Keymed Bio-B Jumps Over 9% in Afternoon Trading, Company Holds Strong Competitive Edge Across Multiple Innovative Drug Areas Including Autoimmune and Oncology

Deep News
·
Sep 29

EU Withdrawal of Aumseqa Exposes Hansoh Pharma's Compliance Gaps and Global Ambitions

Deep News
·
Sep 29

Beyond the Blind Spot: Three Core Signals That Reveal Blue Moon Group's Advanced Logic

Stock News
·
Sep 29

Asian Penny Stocks To Watch In September 2026

Simply Wall St.
·
Sep 29

US Drugmakers Turn to China for Licensing Deals

Reuters
·
Sep 28

Everest Medicines Forms ESG Committee

Stock News
·
Sep 28